News

In The News ADVI’s Lindsay Bealor Greenleaf talks to the Daily Caller about the court blocking Trump’s drug price disclosure requirement for TV ads
In The News ADVI Director, Lindsay Bealor Greenleaf, discussed why including a drug’s list price in direct-to-consumer ads can be misleading to patients with The Daily Caller
In The News ADVI VP Michael Kolodziej discussed creating new alternative payment models for emerging novel therapies at ASCO’s annual meeting with Pink Sheet
In The News ADVI Director Becca Davison discussed with Bloomberg Law the Senate’s HELP Committee’s latest draft bill aimed at reducing health care costs and how it would impact pharmacy benefit managers
In The News Lindsay Bealor Greenleaf talks to the Daily Caller about new drug price transparency requirements for TV ads
In The News ADVI’s Vice President, Dr. Michael Kolodziej, discussed keeping up with healthcare policies coming out of Washington D.C. with AJMC Journal
In The News ADVI’s Lindsay Bealor Greenleaf spoke with Victor Reklaitis about the increased activity from lawmakers and lobbyists regarding drug prices MarketWatch
In The News ADVI’s Lindsay Bealor Greenleaf discussed spread pricing and how PBMs are profiting from State Medicaid programs with Fox Business
In The News ADVI’s Michael Kolodziej discussed the complicated nature of implementing new payment models for oncology with American Journal of Managed Care